PBAC Releases Recommendations from May 2026 Intracycle Meeting
19 Jun 2026
PBAC plays an important role in assessing medicines and vaccines for possible listing on the Pharmaceutical Benefits Scheme (PBS). Its recommendations help guide decisions about which treatments may become more affordable and accessible for Australians.
The newly released recommendations provide an update on medicines and health technologies reviewed during the May 2026 intracycle meeting.
Healthcare professionals, patients, and stakeholders can now access the outcomes and recommendations from the meeting.
PBAC Releases Recommendations from May 2026 Intracycle Meeting
Source: Pharmaceutical Benefits Advisory Committee (PBAC), May 2026 Intracycle Meeting Recommendations
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
Popular Posts
Recent Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy